Telix Pharmaceuticals (TLX.US) Shareholders - Institutional Holders, Major Shareholders & Insiders | Longbridge

Shareholder Type

Institutions43.13%
Public and others37.40%
Individuals & Insiders14.83%
Public companies3.22%
Private companies1.42%

Major Shareholders

Major Shareholders Latest
Shareholder
JPMorgan Chase & Co.	8.96%	30.44M	1.23%	+4.18M	07/21/2026
State Street Investment Management	7.04%	23.93M	1.65%	-5.62M	07/06/2026
Andreas KlugeChief Medical Advisor	6.67%	22.68M	0.01%	+0	02/06/2025
Christian BehrenbruchCo-Founder, MD, Group CEO & Executive Director	6.41%	21.80M	<0.01%	+67.94K	05/26/2026
Challenger Limited	4.98%	16.91M	0.07%	-195.21K	05/04/2026
Citigroup Inc.	3.35%	11.39M	0.01%	+60.42K	06/30/2026
Grand Pharmaceutical Group Limited	3.22%	10.95M	<0.01%	+0	02/06/2026
Vanguard Capital Management, LLC	3.12%	10.59M	<0.01%	+20.67K	07/31/2026
Australian Super Pty Ltd	2.26%	7.69M	<0.01%	+0	12/31/2025
Vanguard Investments Australia Limited	1.88%	6.40M	0.02%	+67.03K	07/31/2026
BlackRock, Inc.	1.75%	5.96M	0.02%	-51.36K	06/30/2026
UV-Cap GmbH & Co KG	1.44%	4.88M	<0.01%	+0	02/06/2026
Norges Bank Investment Management	1.35%	4.60M	0.54%	-1.83M	06/30/2026
Mark NelsonIndependent Non-Executive Director	1.07%	3.63M	<0.01%	+0	03/18/2026
Oncidium Foundation	0.74%	2.51M	<0.01%	+0	02/06/2026
Netwealth Investments Ltd.	0.71%	2.41M	<0.01%	+0	02/06/2026
BetaShares Capital Limited	0.59%	2.01M	0.02%	+51.48K	08/31/2026
Sanlam Investments Uk Limited	0.58%	1.96M	<0.01%	+0	06/30/2025
Lightpoint Medical Ltd	0.56%	1.92M	<0.01%	+0	02/06/2026
Yelwac Pty Ltd	0.52%	1.76M	<0.01%	+0	02/06/2025